Tripeptidyl peptidase II (TPP II) is a large intracellular exopeptidase with an active site of the subtilisin type. Affinitypurified hen antibodies against human erythrocyte TPP II cross-reacted with fibronectin in an immunoblot analysis. Furthermore, antibodies against human fibronectin cross-reacted with TPP II. Antibodies against a 65 kDa cell-binding fragment of fibronectin specifically reacted with TPP II, whereas antibodies against the collagen-binding domain, the main heparin-binding domain or the N-terminal fibrin-binding domain did not react. Moreover, the affinity-purified antibodies against TPP II reacted with a 105 kDa cell-binding fragment of fibronectin but not with the fibrin-binding domain or the collagen-binding domain. When native TPP II was dissociated into smaller units through dialysis against a dilute Tris buffer, it could be digested by chymotrypsin into three stable fragments of 70 kDa, 42 kDa and 20 kDa. It could be demonstrated that the 42 kDa fragment was specifically recognized by antibodies against the 65 kDa cell-binding fragment of fibronectin. Furthermore, labelling with di-[3H]isopropyl phosphorofluoridate and N-terminal sequence determination showed that the 70 kDa fragment contained the active-site serine residue. In conclusion, our findings suggest that one domain of the TPP II molecule bears structural resemblance to a cell-binding fragment of fibronectin.
INTRODUCTION
Tripeptidyl peptidase II (TPP II) is an exopeptidase [1] of an unusually large size, i.e. more than 1000 kDa for the native enzyme and 135 kDa for the subunit [1, 2] . Upon electron microscopy of negatively stained samples [3] , the enzyme displays a few ordered polymeric structures; these can be dissociated into smaller units upon dialysis against a dilute Tris buffer. The dissociation is accompanied by a gradual loss of enzymic activity, indicating that the large polymeric form is a prerequisite for full enzymic activity. The enzyme, which has a neutral pH optimum, has been classified as a serine peptidase [2] . The amino acid sequence around the active-site serine residue is of the subtilisin type [4] . This is in contrast with the other known mammalian serine peptidases, which have an active site of the trypsin type [5] .
TPP II was originally detected in rat liver [1] , but is present in several other rat tissues [2] . The enzyme has also been shown to be present in haemolysates and liver homogenates from other species [6] , as seen both by activity measurements and by the use of antibodies raised against the human erythrocyte enzyme. During attempts to determine the subcellular location of TPP II in human fibroblasts by immunohistochemical techniques, it was noticed that the affinity-purified polyclonal hen antibodies against TPP II reacted towards material with a distribution similar to that of fibronectin (R. Persson, B. Tomkinson & 0. Zetterqvist, unpublished work). In the present work we have investigated the immunological cross-reactivity between TPP II, an intracellular enzyme, and fibronectin, an extracellular matrix protein involved in cell-matrix interactions [7] , with particular reference to the domain structures of the two proteins.
EXPERIMENTAL Materials
Di- [1,3-3H] Human plasma fibronectin, purified as described by Vuento & Vaheri [8] , and fragments thereof were kindly donated by Dr.
Staffan Johansson of this Department. TPP II was prepared from outdated human erythrocytes, essentially as described previously [2, 4] . The resolution in the hydroxyapatite chromatography, used as the last purification step, was improved by stepwise elution with 3 column volumes each of 10 mM-, 50 mm-and 60 mM-potassium phosphate buffer, pH 7.5, containing 300% (w/v) glycerol and 1 mM-dithiothreitol. The enzyme was eluted at the 50 mM-phosphate concentration. Hen antibodies against human TPP II were obtained from Immunsystem A.B. (Uppsala, Sweden). A portion (2 ml containing 27 mg of protein) of the antibody solution was affinitypurified on an AH-Sepharose column conjugated with the denatured 135 kDa peptidase subunit [6] . The eluates from two runs were desalted on Sephadex G-25, pooled, reloaded on to the affinity column and processed through a second chromatography cycle. These affinity-purified antibodies (0.29 mg of protein/ml) were used throughout the work. Rabbit antiserum against human plasma fibronectin and affinity-purified hen antibodies against human plasma fibronectin fragments [9] were generously donated by Dr Alkaline phosphatase-conjugated secondary antibodies, diluted according to the manufacturer's recommendations, in the same buffer as used for primary antibodies, were added and the filters were incubated for an additional 2 h at room temperature. The filters were washed for 40 min with the washing buffer and the antigen was detected by incubation for 20 min-2 h with Nitro Blue Tetrazolium (0.01 %) and 5-bromo-4-chloroindol-3-yl phosphate (0.05 mg/ml) in 0.1 M-ethanolamine/HCl buffer, pH 9.6, containing 3.6 mM-MgCl2. As a control, all immunoblot experiments were also performed with pre-immune antibodies, whereby no detectable staining was seen (results not shown).
Fibronectin-Sepharose column
Fibronectin (5 mg) was dialysed overnight against 0.1 Msodium bicarbonate buffer, pH 8.3, containing 0.5 M-NaCl, and thereafter linked to -0.3 g of CNBr-activated Sepharose 4B according to the manufacturer's recommendations. The gel (1 ml) was equilibrated in phosphate-buffered saline at pH 7.0 containing 0.1 %Tween-80. Affinity-purified hen antibodies against TPP II (2 ml, containing 0.6 mg of protein), prepared as described above, were loaded on to the fibronectin-Sepharose column, and the affinity column was washed and eluted with MgCl2 in the same way as previously described for the TPP I1-Sepharose column [6] . The fractions were analysed by immunoblot analysis as described in Fig. 2 .
Dissociation of TPP II
TPP II [in 50 mM-potassium phosphate buffer, pH 7.5, containing 30 % (w/v) glycerol and I mM-dithiothreitol] was dialysed for 4 h at 4°C against 2 mM-Tris/HCI buffer, pH 8.0, containing 3 % (w/v) glycerol and 0.5 mM-2-mercaptoethanol, as described previously [3] . 7 ) and human fibronectin (diluted in 137 mM-NaCI/4.7 mM-KCI/0.6 mM-MgSO4/ 1.2 mM-CaCl2/10 mM-Hepes/NaOIH buffer, pH 7.4, i.e. buffer 3 [13] ) were all diluted to 2.5 and 12.5 ,ug/ ml, and 0.4 ml of each solution was added to wells in a 24-well plate (Costar). The protein was allowed to adsorb for 1.5 h at 37 'C. Remaining protein-binding sites were blocked by using 0.25 mg of BSA/ml in buffer 3. After 20 min at 37 'C, the wells were washed, once with buffer 3 and once with Dulbecco's modified Eagle's medium (GIBCO, Grand Island, NY, U.S.A.) [14, 15] . Hepatocytes, 4 x I05 in 0.4 ml of Dulbecco's modified
Eagle's medium, isolated from male Sprague-Dawley rats after perfusion of the liver with collagenase as described by Rubin et al. [13] , were seeded in each well and incubated at 37 'C. After 1 h, the wells were washed once with Dulbecco's modified Eagle's medium and the number of cells attached was estimated after lysis in 0.25 o Triton X-100, and determination of the activity of hexosaminidase, as described by Landegren [16] .
Determination of N-terminal amino acid sequences Dissociated TPP 11 (69,tg in the dialysis buffer) was digested with chymotrypsin (2.6 ,g) for 2 h at 30 'C. The reaction was terminated by the addition of sample buffer. The mixture was heated at 55 'C for 15 min before being loaded into ten wells on an 11 % polyacrylamide gel in the presence of SDS, prepared as described above. The separated polypeptides were transferred electrophoretically to an Immobilon membrane, with 50 mmsodium phosphate buffer, pH 6.5, as the transfer buffer. After transfer for 4 h at 400 mA and 4 'C, the membrane was stained with Coomassie Brilliant Blue, as described by Matsudaria [17] . The bands corresponding to 70 kDa, 42 kDa and 20 kDa were cut out from six lanes and analysed by gas-phase sequencing on an Applied Biosystems model 470A protein sequencer. The sequenceable amount varied between 10 and 20 pmol for the three polypeptides.
RESULTS

Cross-reactivity between TPP II and fibronectin
Polyclonal hen antibodies against human erythrocyte TPP II were affinity-purified twice, as described in the Experimental section. When tested against a human fibroblast lysate in an immunoblot analysis (Fig. la, lane 2) , the antibodies reacted with a protein (135 kDa), apparently corresponding to TPP II. In addition, a broad band with molecular mass greater than 200 kDa could be seen on the immunoblot. This band comigrated with isolated human fibronectin, which was found to react with the antibodies against TPP II (Fig. la, lane 4) [2] .
Furthermore, it is evident from lane 8 in Fig. 1(a) by immunoblot analysis against a fibroblast lysate and the crude TPP II preparation (Fig. la, lanes 6 and 7) . It can be noted that, even though several immunoreactive bands can be seen, the bulk of proteins (Fig. lb) were not recognized by these antibodies. It is also a fact that fibronectin is sensitive to proteolytic digestion [18] , indicating that several of the observed immunoreactive bands might be degradation products. The cross-reactivity could also be detected in an immunoblot analysis with commercially available hen antibodies against human fibronectin at a protein concentration of 0.03 mg/ml (results not shown).
A false cross-reactivity might have occurred if traces of fibronectin had been present in the TPP II preparation used for immunization. However, since the 135 kDa TPP II subunit used in the affinity column was electro-eluted from a preparative SDS/polyacrylamide gel, the possibility that the affinity-purified antibody preparation would have contained any fibronectin monospecific antibodies was markedly diminished. In addition, traces of TPP II in the fibronectin preparation were looked for by immunoblot analysis (Fig. I a) and enzymic activity measurement (results not shown), with negative result.
The fact that the antibodies-that were bound to a fibronectin-Sepharose column recognized TPP II as well as fibronectin (Fig. 2 , lanes 5 and 6) further supports the existence of cross-reactivity. Antibodies that did not bind to the column recognized only TPP II in an immunoblot analysis (Fig. 2, lanes  1-4) . Fibronectin can be divided into functional domains through limited proteolysis [19] . Thus a 105 kDa cell-binding fragment, a 40 kDa collagen-binding domain and a 29 kDa fibrin-binding domain have been isolated. Proteolytic fragments, with different fragment size, have also been used for raising antibodies [9] Fig. 2 . Reactivity of anti-(TPP II) antibodies after affinity chromatography on a fibronectin-Sepharose column Affinity-purified hen anti-(TPP II) antibodies (2 ml) were loaded on to a fibronectin-Sepharose column. The column was prepared and eluted as described in the Experimental section. PAGE (8 % gel) and immunoblot analysis were performed as described in the Experimental section. The polyacrylamide gel was loaded with TPP II (1 ,ug in lanes 1, 3 and 5) and fibronectin (10 g in lanes 2, 4 and 6).
The antibodies used were: eluate from sample application (lanes 1 and 2), eluate from first wash (lanes 3 and 4) and Sephadex-G-25-chromatographed MgCl2 eluate from the column (lanes 5 and 6), each at a concentration of about 0.01 mg/ml. ( Fig. 3) [3] seemed to be rather resistant to proteolytic digestion by chymotrypsin, even in an enzyme/substrate molar ratio of 2: 1 (Fig. 5, lanes 1-4) , with the exception of the material represented by the minor bands in the TPP II preparation. This material, which is believed to represent partially degraded subunits (cf. the comments on Fig. 1) , was susceptible to further proteolytic attack, possibly because it is more exposed. When the large polymeric structures were dissociated into smaller units through dialysis against a dilute Tris buffer [3] , the enzyme protein became more sensitive to proteolytic digestion (Fig. 5,  lanes 5-8) . The diference noted was not due to a major change in chymotrypsin activity, since the activity in the Tris buffer used for digestion of dissociated TPP II was 900% of that in the potassium phosphate buffer used for digestion of native TPP II (results not shown). Chymotrypsin attacked a few sensitive bonds, as inferred from the fact that three essentially stable fragments, with apparent molecular masses of 70 kDa, 42 kDa and 20 kDa, were formed.
Investigation of the TPP H fragments
To determine in which of the fragments the serine residue of the active site is located, TPP II was labelled with di-[3H]isopropyl phosphorofluoridate, dialysed and digested with chymotrypsin. By this procedure the active site was found to be part of the 70 kDa fragment (Fig. 6b, lane 2) . (8 ug) was digested with chymotrypsin (0.4,g) for 2 h at 30°C and the digestion was terminated by the addition of sample buffer. The samples were treated as described in the Experimental section, then loaded on to an 11 0% polyacrylamide gel, and the electrophoresis and Coomassie Blue staining were performed as described in the Experimental section. Fluorography, with the use of Amplify, was performed as previously described [2] . The X-ray film was exposed for 14 days. Lane The immunological reactivity of the TPP II fragments was investigated by immunoblot analysis (Fig. 7) . Affinity-purified antibodies raised against native TPP II recognized the 70 kDa fragment and the 42 kDa fragment, but not the 20 kDa fragment. Whether this is due to lack of a sufficient number of antigenic determinants in the 20 kDa fragment, or the possibility that this fragment is not exposed during immunization, is not known. Fig.  7 In a preliminary attempt to investigate the possible structural similarities between TPP II and fibronectin, the N-terminal amino acid sequences of the TPP II fragments were determined after the fragments had been electroblotted on to Immobilon membranes [17] , as described in the Experimental section (Table  1) . For the 20kDa fragment the first 18 residues were easily identified, whereas the 42 kDa fragment was sequenced through only 14 residues. Amino acid sequence similarities between the 42 kDa fragment and human fibronectin were sought by means of the search command 'Bestfit' of the GCG program [20] on a VAX 8200 computer. The best fit showed a 46 % similarity to fibronectin residues 1643-1655, i.e. His-Glu-Leu-Phe-Pro-AlaPro-Asp-Gly-Glu-Glu-Asp-Thr. These residues belong, however, to the extra domain of fibronectin [21] , which is located between the cell-binding and heparin-binding domains of cellular fibronectin. Since this domain is not present in plasma fibronectin, this similarity should not account for the immunological crossreactivity with TPP II. No sequence similarity could be observed between fibronectin and the N-terminal amino acid sequences of the 20 kDa fragment or the 70 kDa fragment.
The N-terminal amino acid sequence of the 70 kDa fragment (Table 1) could not be unambiguously determined beyond the ninth residue, owing to a fairly high background of, in particular, glycine and serine. The data were, however, in agreement with the previous determination of the subtilisin-like amino acid sequence of the active site [4] . It is therefore concluded that residues 3-11 of the 70 kDa fragment are identical with the amino acid sequence surrounding the active-site serine residue [4] . This result is also compatible with the finding above of a di-
[3H]isopropyl label in the 70 kDa fragment (cf. Fig. 6 ) and suggests that the active-site serine residue is located near an exposed hinge region between two domains. It may also be noted that neither the N-terminal amino acid sequence of the 42 kDa fragment nor that of the 20 kDa fragment displayed any sequence similarity to subtilisin.
DISCUSSION
It has been established in this paper that there is an immunological similarity between the cell-binding fragment of human fibronectin and a 42 kDa fragment of human TPP II. However, no cell-binding property of TPP II could be detected, nor could a significant structural relationship between fibronectin and the N-terminal part (14 amino acid residues) of the 42 kDa fragment be observed. It is therefore possible that a common antigenic determinant between TPP II and fibronectin either lies in other parts of the 42 kDa TPP II fragment or is a feature of the three-dimensional structure.
The cell-binding domain of fibronectin consists of a number of repeating units (type III repeats) [7] . These units are, however, not restricted to fibronectin, since type III repeats have also been observed in another extracellular matrix glycoprotein, cytotactin [22] . The possibility that the cross-reactivity observed between TPP II and fibronectin might be due to the existence of type-III- Lys-Thr-Asp-Pro-Arg-Pro-Asp-Ala-Ala-Thr-Ile-Lys-Asn-Asp-Met-Asp-Lys-Gln-Xaa-Ser His-Gly-Leu-Leu-Pro-Lys-Lys-Glu-Thr-Xaa-Ala-Ala-Ser-Phe Arg-Gly-Thr-Gln-Leu-Met-Asn-Gly-Thr-(Ser)-(Met)
Vol. 267 like repeats also in TPP II may therefore be considered. It has been suggested, e.g. for the serine proteinases involved in blood coagulation and fibrinolysis [23] , and for immunoglobulins [24] , that proteins evolve partly by combining genetic elements, which specify protein domains with different functions. If this is the case also for the large TPP II protein, the cross-reactivity between fibronectin and TPP II may imply a role for the peptidase in the extracellular matrix, in addition to its role as an intracellular peptidase.
The immunological cross-reactivity between TPP II and fibronectin, studied in this work, indicates structural similarities between the two proteins. However, more definite statements on the nature, as well as the functional implications, of such similarities will have to await the determination of the full amino acid sequence of the enzyme and the demonstration of possible similarities to the fibronectin amino acid sequence.
